BioAsia 2023 forum to discuss challenges & opportunities in Life Science post-COVID
![Mr. Glenn Saldanha, Chairman And Managing Director, Glenmark Pharmaceuticals, and Dr. Gagandeep Kang, Virologist, and Professor, Dept. of Gastrointestinal Sciences, CMC Vellore will be among the distinguished speakers. (Photo by arrangement) Mr. Glenn Saldanha, Chairman And Managing Director, Glenmark Pharmaceuticals, and Dr. Gagandeep Kang, Virologist, and Professor, Dept. of Gastrointestinal Sciences, CMC Vellore will be among the distinguished speakers. (Photo by arrangement)](https://s3.ap-southeast-1.amazonaws.com/images.deccanchronicle.com/dc-Cover-32vopcvu6gd53uffss4u00qbr4-20230111204103.Medi.jpeg)
HYDERABAD: The pandemic has brought into sharp focus the critical need for industry, academia, governments, regulators, and other stakeholders in the ecosystem to intensify their collaboration for ensuring healthcare innovation at scale and delivery with equitable access. In this context, the 20th edition of BioAsia - the marquee healthcare and Life Sciences event, organized by
the Government of Telangana, will feature prominent government dignitaries, industry leaders, researchers, entrepreneurs, and other delegates, and explore the theme of Advancing for ONE: Shaping the next generation of humanized healthcare.
The event is scheduled to be held between February 24 and 26, 2023 at the Hyderabad International Convention Center (HICC) in Hyderabad. Ernst and Young will be the knowledge partner of the event.
Moving back to a in-person format, Asia’s largest life-sciences and healthcare forum BioAsia 2023, will witness the participation of some of the most renowned and influential global leaders. The speakers will highlight the growing role of India in the global life sciences market and also deliberate on the opportunities / challenges for India as the companies look to scale further heights.
Commenting on the presence of the Lifesciences industry at BioAsia 2023, Mr. K.T. Rama Rao, Minister of IT, said, “Telangana has been playing a significant role in strengthening the positioning of the country in the worldwide life sciences industry. Several key global players have been leveraging the ecosystem
provided by the state by setting up their operations in the state. BioAsia has created a legacy by providing a platform for global leaders to deliberate on healthcare's key requirements over the last 20 years. I am confident that the world will continue to hear and learn from the brilliant minds at the
conference.”
The theme of this edition is “Advancing for ONE: Shaping the next generation of humanized healthcare”. Over the course of the three days, prominent industry leaders, distinguished scientists, researchers, and entrepreneurs will come together to discuss humanizing healthcare and will hold constructive discussions on how cross-sectional ecosystems can be integrated, how disruptive technologies can be best utilized, and how we can drive quality healthcare with accessibility and affordability at the forefront in the near future.